NewGenIvf Group Limited Warrants
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more
NewGenIvf Group Limited Warrants (NIVFW) - Total Assets
Latest total assets as of September 2025: $35.56 Million USD
Based on the latest financial reports, NewGenIvf Group Limited Warrants (NIVFW) holds total assets worth $35.56 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NewGenIvf Group Limited Warrants - Total Assets Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Warrants’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NewGenIvf Group Limited Warrants - Asset Composition Analysis
Current Asset Composition (December 2024)
NewGenIvf Group Limited Warrants's total assets of $35.56 Million consist of 88.7% current assets and 11.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.8% |
| Accounts Receivable | $2.36 Million | 66.0% |
| Inventory | $80.81K | 2.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how NewGenIvf Group Limited Warrants's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NewGenIvf Group Limited Warrants's current assets represent 88.7% of total assets in 2024, an increase from 58.1% in 2021.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2024, up from 2.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 66.0% of total assets.
NewGenIvf Group Limited Warrants Competitors by Total Assets
Key competitors of NewGenIvf Group Limited Warrants based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
NewGenIvf Group Limited Warrants - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - NewGenIvf Group Limited Warrants generates 1.52x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NewGenIvf Group Limited Warrants is currently not profitable relative to its asset base.
NewGenIvf Group Limited Warrants - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.43 | 0.28 | 0.65 |
| Quick Ratio | 3.37 | 0.21 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.93 Million | $ -2.51 Million | $ -41.01K |
NewGenIvf Group Limited Warrants - Advanced Valuation Insights
This section examines the relationship between NewGenIvf Group Limited Warrants's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -20.3% |
| Total Assets | $3.58 Million |
| Market Capitalization | $2.34K USD |
Valuation Analysis
Below Book Valuation: The market values NewGenIvf Group Limited Warrants's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NewGenIvf Group Limited Warrants's assets decreased by 20.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NewGenIvf Group Limited Warrants (2021–2024)
The table below shows the annual total assets of NewGenIvf Group Limited Warrants from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.58 Million | -20.26% |
| 2023-12-31 | $4.49 Million | -93.66% |
| 2022-12-31 | $70.79 Million | +4910.49% |
| 2021-12-31 | $1.41 Million | -- |